Skip to content

Post Study Continuation of C7 for G1D

Post Study Continuation of C7 for G1D

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT02018302
Enrollment
Unknown
Registered
2013-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Transporter Type 1 Deficiency Syndrome, Glut1 Deficiency Syndrome

Keywords

G1D, Glut1 Deficiency, Glucose Transporter Type 1 Deficiency, Glucose Transporter Type I Deficiency

Brief summary

This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.

Detailed description

Only patients who completed the initial pilot study were eligible. The study is ongoing with these patients only.

Interventions

DRUGTriheptanoin

Sponsors

Juan Pascual
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
1 Months to 28 Years
Healthy volunteers
No

Inclusion criteria

* Patients enrolled in the pilot trial (UTSW 122010-186)

Exclusion criteria

* Subjects who did not complete the pilot trial (UTSW 122010-186)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026